Back

Science Advances

52 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Genetic insights into immunothrombosis: from shared loci to repurposed drugs for autoimmune and thrombotic diseases
2026-03-03 hematology 10.64898/2026.02.28.26346627
#1 (3.9%)
Show abstract

ObjectiveAutoimmune diseases (ADs) markedly elevate venous thromboembolism (VTE) risk, yet the shared genetic architecture and tissue-specific regulatory mechanisms of this "Autoimmune-Thrombotic Axis" remain poorly defined. We aimed to characterize the genomic landscape of immunothrombosis to identify causal links and therapeutic targets. Approach and ResultsWe integrated large-scale GWAS data for VTE and 16 ADs using a multi-omics framework, including pleiotropy scanning, local genetic correl...

2
Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
2026-03-02 hematology 10.64898/2026.02.22.26346823
Top 0.2% (2.0%)
Show abstract

Allogeneic hematopoietic cell transplantation (allo-HCT) hinges on a delicate trade-off between graft-versus-tumor control and graft-versus-host disease (GvHD), mediated by donor T-cell recognition of antigens presented by recipient human leukocyte antigen (HLA) molecules. We hypothesized that, beyond allele-level matching, sequence divergence at peptide-binding grooves across donor and recipient HLA loci shapes these responses. To this end, we evaluated the effect of HLA evolutionary divergence...

3
Development and Internal Validation of the AB-IPI using Bootstrapping: A Clinicopathological Prognostic Score Integrating Host Fitness and Tumor Biology in Diffuse Large B-Cell Lymphoma
2026-02-19 hematology 10.64898/2026.02.18.26346527
Top 0.2% (2.0%)
Show abstract

ObjectivesThe therapeutic efficacy of rituximab has reduced the discriminatory power of the International Prognostic Index (IPI) in diffuse large B-cell lymphoma (DLBCL), particularly within intermediate-risk categories. To address this "risk dilution," we aimed to develop and internally validate the AB-IPI (Albumin-BCL2 Refined Prognostic Index) using a hypothesis-driven approach that integrates tumor burden, host fitness, and tumor biology. MethodsThis multi-center retrospective study analyze...

4
Substance P, mast cells and basophils are involved in acute chest syndrome in sickle cell disease
2026-03-03 hematology 10.64898/2026.03.02.26347450
Top 0.3% (1.9%)
Show abstract

A role for substance P in promoting neurogenic inflammation and pain has been described in sickle cell disease (SCD). However its origin and contribution to SCD pathophysiology remain unclear. We measured substance P level in plasma from 225 patients with SCD and observed the highest concentrations during acute chest syndrome (ACS). Therefore, we tested the hypothesis that substance P may induce ACS. In transgenic sickle mice, unlike control mice, intravenous injection of substance P caused leth...

5
TracMyAir: Smartphone-enabled spatiotemporal estimates for inhaled doses of particulate matter and ozone to personalize health outcomes
2026-02-16 public and global health 10.64898/2026.02.13.26346275
Top 0.3% (1.9%)
Show abstract

Accurate quantification of individual exposure to air pollutants remains a major challenge in environmental health, as fixed-site monitoring fails to account for mobility, indoor environments, and physiological variability. We deployed TracMyAir, a smartphone-based digital health platform designed to generate time-resolved, personalized exposure and inhaled dose estimates for PM2.5 and ozone under real-world conditions. In an exploratory study of 18 adults contributing more than 1,500 participan...

6
Plasma proteome signatures in sickle cell anaemia and effect of hydroxyurea treatment
2026-02-10 hematology 10.64898/2026.02.08.26345875
Top 0.4% (1.8%)
Show abstract

BackgroundSickle Cell Anaemia (SCA), a genetic blood disorder caused by a single mutation in the beta globin gene, displays a highly variable clinical course. Hydroxyurea (HU), an effective treatment, has an unclear mechanism of action. Plasma proteins can act as biomarkers for understanding disease states and response to HU treatment in SCA patients. MethodsPlasma proteome profiling of 31 healthy individuals and 76 SCA patients, including those with and without HU treatment, was performed usin...

7
The need for balanced dengue vaccine protection: Insights from Thai surveillance data on four serotypes
2026-03-02 epidemiology 10.64898/2026.02.26.26347232
Top 0.5% (1.8%)
Show abstract

Dengue virus (DENV), comprising four distinct serotypes (DENV-1 to DENV-4), poses a major public health challenge in tropical regions. Infection with one serotype confers long-term immunity to that serotype alone, while subsequent heterologous infections are associated with increased risk of severe disease, necessitating vaccines that induce durable, balanced immunity across all serotypes. However, achieving such balance immunity remains a central challenge for dengue vaccine development. Using ...

8
Development of a network for interactions and associations among biopsychosocial features of chronic low back pain
2026-02-11 pain medicine 10.64898/2026.02.09.26345929
Top 0.5% (1.7%)
Show abstract

BackgroundUnderstanding the associations among biopsychosocial factors is essential for improving research and treatment of chronic low back pain (CLBP). Here we characterized interrelations among biopsychosocial domains using network analysis and identified the most influential features in CLBP. MethodsData came from Quebec Low Back Pain Study, comprising 4,489 CLBP participants. We modeled relationships among baseline biopsychosocial features as networks, where nodes represent features and ed...

9
Sex-stratified Integrated Analysis of US lung Cancer Mortality, 1994-2020
2026-03-06 oncology 10.64898/2026.03.01.26347234
Top 0.7% (1.5%)
Show abstract

Importance: Lung cancer mortality in the United States has fallen substantially in recent decades, yet the relative influence of behavioral, environmental, socioeconomic, and therapeutic factors and their sex specific contributions remains unclear. Understanding these drivers is essential to sustain progress and reduce persistent disparities. Objective: To quantify how behavioral, environmental, socioeconomic, and therapeutic determinants collectively shaped US lung cancer mortality from 1994 to...

10
Systems Biology and Machine Learning Decode an Immunometabolic Signature for Post-Thrombotic Syndrome
2026-02-11 hematology 10.64898/2026.02.09.26345941
Top 0.7% (1.5%)
Show abstract

ObjectivePost-thrombotic syndrome (PTS), a common complication of deep vein thrombosis, lacks objective diagnostic biomarkers and its molecular mechanisms remain poorly understood. This study aimed to identify plasma biomarkers and clarify pathways using integrated multi-omics and machine learning. MethodsProteomic and metabolomic profiling of 75 PTS patients and 75 controls was performed. Differential expression analysis, pathway enrichment, and protein-metabolite network analysis were conduct...

11
Air pollution exposure in Generation Scotland: molecular fingerprints and health outcomes
2026-03-04 epidemiology 10.64898/2026.03.04.26347573
Top 0.8% (1.5%)
Show abstract

Ambient air pollution has been associated with increased incidence of chronic disease and is estimated to contribute towards 4.2 million early deaths annually. Whilst the health impacts are well described, less is understood about the underlying biological mechanisms, particularly when considering the co-occurrence of multiple pollutants. Using an atmospheric chemistry transportation model (EMEP4UK), we generate pre-baseline sampling pollution exposure estimates for eight pollutants in Generatio...

12
The (mis-)alignment of genetic association studies to global health needs
2026-02-11 public and global health 10.64898/2026.02.09.26345919
Top 0.9% (1.5%)
Show abstract

Health research priorities are generally not aligned with global disease burden. Although genome-wide association studies (GWAS) are correcting a historical bias by including samples from different demographic groups, this does not necessarily translate to improved understanding of the most important causes of disease globally. We demonstrate that while in countries with high socioeconomic development index (SDI) there is some alignment between the traits being analysed in GWAS and those that co...

13
A Mendelian randomization-based drug repurposing pipeline
2026-03-02 epidemiology 10.64898/2026.02.28.26347341
Top 1.0% (1.5%)
Show abstract

Drug repurposing offers the opportunity to identify promising drug targets efficiently using existing data, but there are currently limitations to these efforts; there is a particular need for versatile, but rigorous high-throughput approaches. As such, we developed a flexible, high-throughput, Mendelian randomization (MR)-based drug repurposing pipeline with three stages: 1) MR-based identification, 2) MR-based validation and prioritization, and 3) application. This pipeline can be applied to a...

14
Gut microbiome and metabolome reveal hormone-related and functional alterations in ER-positive breast cancer: a case-control study
2026-02-09 epidemiology 10.64898/2026.02.06.26345778
Top 1% (1.5%)
Show abstract

The gut microbiome has been linked to breast cancer, largely through microbial functions involved in estrogen metabolism (the "estrobolome"); however, specific microbial targets remain poorly defined in human studies. Here, we profiled the gut microbiome using whole-metagenome shotgun sequencing, and plasma and stool metabolites were quantified using targeted metabolomics, in a study of 70 postmenopausal female cases with treatment-naive ER-positive breast cancer and 70 controls. Reduced species...

15
Bridging the Genomic Equity Gap with Context-Enhanced Risk Stratification in American Indians: the Strong Heart Study
2026-02-11 genetic and genomic medicine 10.64898/2026.02.08.26345859
Top 1% (1.4%)
Show abstract

Polygenic scores (PGS) show promise for disease risk stratification but suffer from limited portability across populations. American Indians face a disproportionate burden of cardiovascular disease yet remain significantly underrepresented in genomic research, limiting equitable access to precision medicine. Here, we evaluate whether integrating specific lifestyle and clinical context variables with PGS enhances risk prediction for cardiometabolic traits in 424,622 European from UK Biobank (UKB)...

16
Metabolic Adaptations to Long-Term Caloric Restriction: Principal Components Analysis of Mass-Spectrometry Metabolomics from the CALERIE™ Phase 2 Trial
2026-02-24 nutrition 10.64898/2026.02.20.26346654
Top 1% (1.4%)
Show abstract

BackgroundCaloric restriction (CR) improves markers of biological aging, yet long-term effects on the human metabolome remain unclear. ObjectiveThis study examined the effects of CR (2 years) in healthy adults without obesity on circulating metabolites linked to aging and metabolic adaptations. MethodsUntargeted metabolomics was performed using fasted plasma samples collected at baseline, 12, and 24 months (BL, 12M, 24M) from CALERIE participants randomized to CR or ad libitum (AL) control. A ...

17
Poor Sleep Health Traits Influence Liking of Sweet Foods and Sugary Food Intake: A UK Biobank Study
2026-02-17 nutrition 10.64898/2026.02.15.26346360
Top 2% (1.3%)
Show abstract

Poor sleep is linked to consumption of sugary foods/beverages and high neural responsivity to palatable food cues. Yet, whether hedonic liking for sweet taste explains these associations remains unclear. We examined cross-sectional associations of five sleep traits (chronotype, sleep duration, insomnia frequency, snoring, daytime dozing) and a composite sleep score with sweet food liking, and total and free sugar intake in 76,734 UK Biobank participants (39-72 years, 56.3% female). Models adjust...

18
Three Dimensions of Compounding Neglect: How Biobanks, Clinical Trials, and Scientific Literature Systematically Exclude the Global South
2026-02-11 public and global health 10.64898/2026.02.10.26346004
Top 2% (1.3%)
Show abstract

Global health inequities are widely documented in outcomes. However, the research systems that generate knowledge, trials, and discovery have rarely been evaluated as an integrated structure. We introduce the Health Equity Informative Metrics (HEIM) framework, a three-dimensional audit of discovery (biobank output), translation (clinical trial activity), and knowledge (semantic organisation of the scientific literature). Analysing 70 international biobanks, 563,725 registered clinical trials, 13...

19
TRAF1 S146 is constitutively phosphorylated in primary CLL cells by PKN1/2
2026-02-17 oncology 10.64898/2026.02.11.26346036
Top 2% (1.3%)
Show abstract

TRAF1 is a pro-survival signaling adaptor that contributes to NF-{kappa}B activation downstream of a subset of TNFR superfamily members. TRAF1 is overexpressed in many cancers of mature B cells, including chronic lymphocytic leukemia (CLL). Previous studies have established that TRAF1 S146 is a target of phosphorylation by the kinase PKN1 and that PKN1 is required to prevent cellular inhibitor of apoptosis protein (cIAP)-dependent degradation of TRAF1 in the CD40 signaling complex. The kinase in...

20
Mediation of the relationship between air pollution and dementia: A UK Biobank study.
2026-02-22 epidemiology 10.64898/2026.02.20.26346698
Top 2% (1.2%)
Show abstract

BackgroundAir pollution is a potentially modifiable risk factor for dementia with a population attributable risk fraction of 3%. Little is known about the causal mechanisms behind the association, so we aimed to investigate this. MethodsData from the UK Biobank were used to investigate the association between six measures of air pollution (NO2, NOx, PM2{middle dot}5-10, PM2{middle dot}5, PM2{middle dot}5 absorbance and PM10) and dementia incidence. Indirect pathways through four mediators (card...